Logo

Starry-Eyed CEO

Mar 12, 2007

Sidney Taurel, the chairman and CEO of Eli Lilly, has a sunny outlook on the progress in biomedical research. In the Boston Herald, he writes that this field has not fizzled out but is on the verge of discovering answers and cures to many diseases -- and it will be almost "miraculous." He notes that "human mortality will always equal 100 percent," but he sure seems confident that Lilly scientists will overcome all problems right up until the end. Or maybe he's just looking for new stockholders.

Breaking News
The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.